BrightSpring Health Services Increases FY24 Guidance: Sees Revenue Of $10.45B-$10.90B Vs. $10.61B Estimate (Prior View: $10.30B- $10.80B)
Portfolio Pulse from Benzinga Newsdesk
BrightSpring Health Services has increased its FY24 guidance, projecting net revenue between $10.45 billion and $10.90 billion, surpassing the previous estimate of $10.30 billion to $10.80 billion. The Pharmacy Segment is expected to see significant growth, with revenue between $8.00 billion and $8.40 billion, while the Provider Segment is projected to grow more modestly. Adjusted EBITDA is forecasted to be between $570 million and $580 million.
August 02, 2024 | 10:48 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BrightSpring Health Services has raised its FY24 revenue guidance to $10.45 billion-$10.90 billion, exceeding previous estimates. The Pharmacy Segment is expected to see substantial growth, while the Provider Segment will grow more modestly. Adjusted EBITDA is also projected to increase.
The increase in revenue guidance and significant growth projections for the Pharmacy Segment are positive indicators for BrightSpring Health Services. This is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100